Infinity Pharmaceuticals shares are trading lower after it terminated its previously announced merger agreement with MEI Pharma.
Portfolio Pulse from Benzinga Newsdesk
Infinity Pharmaceuticals has terminated its previously announced merger agreement with MEI Pharma, causing its shares to trade lower.
July 24, 2023 | 12:43 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Infinity Pharmaceuticals' stock is trading lower after the termination of its merger agreement with MEI Pharma.
The termination of the merger agreement with MEI Pharma is a significant event for Infinity Pharmaceuticals. This could lead to uncertainty among investors, causing a decrease in demand for the company's shares and thus leading to a lower share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100